| FSSNX | SLPAX | FSSNX / SLPAX | |
| Total Expense Ratio | 0.03 | 0.42 | 6% |
| Annual Report Gross Expense Ratio | 0.03 | 0.72 | 3% |
| Fund Existence | 15 years | 30 years | - |
| Gain YTD | 20.765 | 16.400 | 127% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 34.9B | 202M | 17,277% |
| Annual Yield % from dividends | 1.02 | 0.94 | 109% |
| Returns for 1 year | 35.03 | 1.05 | 3,331% |
| Returns for 3 years | 61.18 | 23.77 | 257% |
| Returns for 5 years | 41.83 | -18.02 | -232% |
| Returns for 10 years | 149.70 | -6.73 | -2,224% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 38.32 | N/A | N/A |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| SPBW | 28.78 | -0.06 | -0.22% |
| AllianzIM Buffer20 Allocation ETF | |||
| SMIG | 33.12 | -0.09 | -0.27% |
| Bahl & Gaynor Sm/Md Cp Inc Gr ETF | |||
| IJAN | 37.98 | -0.17 | -0.45% |
| Innovator Itnl Dvp Pwr Buff ETF™ Jan | |||
| MBCE | 38.69 | -1.03 | -2.59% |
| Monarch Blue Chips Elite Index ETF | |||